BROADWOOD PARTNERS LP 13D/13G Filings for OncoCyte Corporation (OCX)

BROADWOOD PARTNERS LP 13D and 13G filings for OncoCyte Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-10
8:46 pm
Purchase		 2025-02-06 13D OncoCyte Corporation
OCX		 BROADWOOD PARTNERS LP 11,560,350
40.200%		 6,481,034increase
(+127.60%)		 Filing
2024-04-15
7:26 pm
Purchase		 2024-04-11 13D OncoCyte Corporation
OCX		 BROADWOOD PARTNERS LP 5,079,316
37.600%		 5,079,316increase
(New Position)		 Filing